Search results
The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system diseases.
Kyowa Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.
Kyowa Kirin Co., Ltd. (協和キリン株式会社, Kyōwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue.
Kyowa Kirin Asia Pacific is a Japan-based Global Specialty Pharmaceutical Company that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system diseases.
Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs. Kyowa Kirin International is a subsidiary of Kyowa Kirin Co., Ltd. the Japan-based global specialty pharmaceutical company.
May 14, 2024 · With over 500 people focused on this purpose we've become a highly successful and rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of innovative medicines for the treatment of unmet therapeutic needs. Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan.
May 31, 2024 · This is the Kirin Holdings Kyowa Kirin page under the Pharmaceuticals domain page. It includes the specific business activities and product brands in the three main domains of the Kirin Group (Food & Beverages, Health Science and Pharmaceuticals).
